United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2666_71c2dd8a-818a-444b-bdfb-9f8b6bc55f3a
- Product NDC
- 71335-2666
- Form
- TABLET
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250219
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 40 TABLET in 1 BOTTLE (71335-2666-0) · 71335-2666-0
- 14 TABLET in 1 BOTTLE (71335-2666-1) · 71335-2666-1
- 84 TABLET in 1 BOTTLE (71335-2666-2) · 71335-2666-2
- 30 TABLET in 1 BOTTLE (71335-2666-3) · 71335-2666-3
- 20 TABLET in 1 BOTTLE (71335-2666-4) · 71335-2666-4
- 15 TABLET in 1 BOTTLE (71335-2666-5) · 71335-2666-5
- 60 TABLET in 1 BOTTLE (71335-2666-6) · 71335-2666-6
- 90 TABLET in 1 BOTTLE (71335-2666-7) · 71335-2666-7
- 56 TABLET in 1 BOTTLE (71335-2666-8) · 71335-2666-8
- 120 TABLET in 1 BOTTLE (71335-2666-9) · 71335-2666-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →